In Wyeth, Pfizer Sees a Drug Pipeline
Monday, January 26, 2009 - 19:49
in Psychology & Sociology
Pfizer’s planned acquisition of Wyeth is a validation of Wyeth’s decision to reduce its reliance on small-molecule drugs.
Pfizer’s planned acquisition of Wyeth is a validation of Wyeth’s decision to reduce its reliance on small-molecule drugs.